Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection

Summary

The goal of this clinical study is to check if obeldesivir (ODV; GS-5245) is safe and well-tolerated by children with respiratory syncytial virus (RSV) infection. It will also look at how well ODV helps reduce the time it takes for children to feel better and for their RSV symptoms to improve. The primary objectives of this study are: a) to evaluate the safety and tolerability of ODV in pediatric participants with RSV infection; b) To evaluate the efficacy of ODV on time to alleviation of targeted RSV symptoms in pediatric participants with RSV infection.

Timeline

Start

2025-03-05

Primary completion

2025-04-16

Completion

2025-04-16

Outcome

Outcome not reported

Stopped: “Study was terminated by Sponsor; the decision was not due to any safety findings.”

Drugs

Indications